Current Pediatric Research

The management protocols in children are mainly governed by symptoms severity and atypical cases. COVID-19 in pediatric group of patients can be asymptomatic. The aim to conduct the study was to assess the benefits and timely management of COVID19 when it is transmitted from the silent carriers like children. The two research questions below were determined.

• Whether children are more dangerous than adults in spreading of infection?
• How long lasts viral shedding after recovery?

We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Abstracts of Reviews of Effects, as well as foreign literature with English translations. Extra information and data have been collected from Google Scholar and American Society for Microbiology (ASM). No randomized controlled trial studies had been conducted in children with COVID-19 yet. Information on patients’ age range, comorbidities, methods of treatment, and effects on mortality, morbidity were extracted. As a conclusion, this study shows that children are less susceptible to COVID- 19 disease than adults, also the symptoms are less sever than in adults and with regard to transmission, no evidence suggesting vertical transmission (intrauterine) except one case or through breastfeeding of COVID-19 virus. Finally, children are much immune than any other age group and this immunity is more resistant to COVID-19 as this is explained in details[1].

Author(s): Majid Mohammed Mahmood, Ilhama Jafarli, Aras Fathi Al-Barazanchi, Nadhim Mohammed Mosa, Zaidoon Walid Mahmood Almashhadani and Zenab Ghanim Younus Al-Ameen

Abstract | PDF

Share this